[HTML][HTML] Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells

T Hirota, N Kunitoku, T Sasayama, T Marumoto… - Cell, 2003 - cell.com
Aurora family kinases contribute to regulation of mitosis. Using RNA interference in
synchronized HeLa cells, we now show that Aurora-A is required for mitotic entry. We found that …

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway

…, Y Kawano, D Murakami, T Sasayama… - The Journal of cell …, 2001 - rupress.org
CD44 is a widely distributed cell surface adhesion molecule and is implicated in diverse
biological processes. However, the nature of intracellular signaling triggered by CD44 remains …

MicroRNA‐10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC

T Sasayama, M Nishihara, T Kondoh… - … journal of cancer, 2009 - Wiley Online Library
MicroRNAs (miRNAs) are effective post‐transcriptional regulators of gene expression and
are important in many biological processes. Although the oncogenic and tumor suppressive …

[PDF][PDF] CENP-A phosphorylation by Aurora-A in prophase is required for enrichment of Aurora-B at inner centromeres and for kinetochore function

N Kunitoku, T Sasayama, T Marumoto, D Zhang… - Developmental cell, 2003 - cell.com
The Aurora (Ipl1)-related kinases are universal regulators of mitosis. We now show that
Aurora-A, in addition to Aurora-B, regulates kinetochore function in human cells. A two-hybrid …

Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment

K Tanaka, T Sasayama, Y Irino… - The Journal of …, 2015 - Am Soc Clin Investig
The mechanistic target of rapamycin (mTOR) is hyperactivated in many types of cancer,
rendering it a compelling drug target; however, the impact of mTOR inhibition on metabolic …

Roles of aurora‐A kinase in mitotic entry and G2 checkpoint in mammalian cells

…, N Kunitoku, D Zhang, Y Ichikawa, T Sasayama… - Genes to …, 2002 - Wiley Online Library
Background : Various mitotic events are controlled by Cdc2‐cyclin B and other mitotic kinases.
Aurora/Ipl1‐related mitotic kinases were proved to play key roles in mitotic progression in …

PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas

…, L Wang, M Squatrito, T Sasayama… - Genes & …, 2010 - genesdev.cshlp.org
Gene rearrangement in the form of an intragenic deletion is the primary mechanism of oncogenic
mutation of the epidermal growth factor receptor (EGFR) gene in gliomas. However, the …

[PDF][PDF] Morbidity of stereotactic biopsy for intracranial lesions

M Nishihara, T Sasayama, H Kudo… - The Kobe journal of the …, 2010 - med.kobe-u.ac.jp
MATERIALS AND METHODS CT-guided STB (Brown-Roberts-Wells; BRW) was performed
58 times for 56 patients at Hyogo Cancer Center between 1988 and 2007. The diagnosis …

Intracranial myxoid mesenchymal tumor with EWSR1CREB1 gene fusion: a case report and literature review

…, A Yoshida, K Tanaka, K Matsuo, T Sasayama… - Brain Tumor …, 2020 - Springer
Intracranial myxoid mesenchymal tumors harboring EWSR1 fusions with CREB transcriptional
factor gene families were recently described in several case reports and a few case series …

De-Repression of PDGFRβ Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients

…, WH Yong, M Flagg, F Tamanoi, T Sasayama… - Cancer discovery, 2013 - AACR
Acquired resistance to tyrosine kinase inhibitors (TKI) represents a major challenge for
personalized cancer therapy. Multiple genetic mechanisms of acquired TKI resistance have been …